Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, Peru

por Vargas-Herrera, Natalia, Fernández-Navarro, Manuel, Cabezudo, Nestor E., Soto-Becerra, Percy, Solís-Sánchez, Gilmer, Escobar-Agreda, Stefan, Silva-Valencia, Javier, Pampa-Espinoza, Luis, Bado-Pérez, Ricardo, Solari, Lely, Araujo-Castillo, Roger V.
Publicado 2022